Parametric Portfolio Associates’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$6.27M Buy
373,979
+114,874
+44% +$1.9M ﹤0.01% 1701
2021
Q4
$6.09M Buy
259,105
+129,628
+100% +$3M ﹤0.01% 1718
2021
Q3
$2.84M Buy
129,477
+90,047
+228% +$2.19M ﹤0.01% 2199
2021
Q2
$1.09M Buy
+39,430
New +$1.08M ﹤0.01% 2728
2021
Q1
Sell
-57,080
Closed -$1.7M 4052
2020
Q4
$1.7M Buy
+57,080
New +$1.69M ﹤0.01% 2770
2020
Q3
Sell
-36,644
Closed -$818K 3935
2020
Q2
$818K Buy
+36,644
New +$828K ﹤0.01% 3027

Other funds holding CLVT

Parametric Portfolio Associates's CLVT Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Clarivate (CLVT) stake by 44% in Q1 2022, buying an estimated $1.9M and bringing the position to 373,979 shares worth $6.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1701.

Parametric Portfolio Associates first reported a position in CLVT in Q2 2020 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold CLVT as of Q1 2022.

  • Parametric Portfolio Associates held 373,979 shares of Clarivate worth $6.27M as of Q1 2022.
  • Parametric Portfolio Associates bought 114,874 Clarivate shares in Q1 2022, an estimated $1.9M.
  • Clarivate made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1701 holding.
  • Parametric Portfolio Associates first reported a position in Clarivate in Q2 2020 and has held it in 6 quarters since.
  • 285 funds tracked by Wall St. Rank held Clarivate as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.